Bayer Corp. and Janssen Pharmaceuticals Inc. (a unit of Johnson & Johnson) have been sued in a California lawsuit by 12 people injured from using the companies’ blood thinner Xarelto. The plaintiffs who filed the California lawsuit were taking Xarelto to treat atrial fibrillation or to prevent the occurrence of dangerous blood clots. After taking the drug, they experienced either rectal or gastrointestinal bleeding, which required hospitalization in some cases. One man suffered a stroke.
Bayer and Johnson & Johnson Did Not Warn Sufficiently of Xarelto’s Risk of Severe Bleeding
The California Xarelto lawsuit reportedly alleges that Xarelto’s box label did not adequately warn about the risk of severe bleeding associated with the drug. In addition, the drug makers told health care providers that it was unnecessary to perform follow-up blood testing on patients using the drug, even though this was not the case.
The lawsuit pointed out that while the pharmaceutical companies have been aggressively marketing Xarelto and raking in a huge financial bounty, American citizens who have used the drug continue to be at risk for severe internal bleeding and death.
So many Xarelto lawsuits have been filed in locations around the country, that they have been consolidated in federal court in Louisiana and in state court in Philadelphia, Pennsylvania.
Contact Waters Kraus & Paul to Learn More About Filing a Xarelto Lawsuit
If you have suffered injuries or the death of a loved one associated with Xarelto,contact us by email or call our Xarelto attorneys at 800.226.9880 to learn more about how we can assist you with a Xarelto lawsuit.